Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 36722048.
- Also identified by DOI 10.1093/infdis/jiad026 and PMC identifier 10686687.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fewer than half of the world's infants have access to the birth dose of hepatitis B vaccine (HBV), which prevents mother-to-child transmission of HBV and subsequent liver cancer. Now is the time to expand access for infants born in low-resource settings.
Medical subject headings
- Hepatitis B
- Liver Neoplasms
- Pregnancy Complications, Infectious